Inflammation and benign prostatic hyperplasia.
Prostatitis, a histologic diagnosis, has evolved over the years to describe a clinical syndrome that was believed to be associated with prostatic inflammation. Similarly, benign prostatic hyperplasia (BPH), another histologic diagnosis, has evolved to describe a clinical syndrome believed to be associated with prostatic enlargement. Recent explorations of the interrelationships between these prostate-associated histologic and clinical conditions have generated much interest and excitement. This article describes these relationships and their impact on the management of, in particular, BPH.
Department of Urology, Queen's University, Kingston, Ontario, Canada. jcn@queensu.ca
J Curtis
JC
Nickel
D015415:Biomarkers; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000145:classification / Q000209:etiology / Q000473:pathology*; D011472:Prostatitis / Q000145:classification* / Q000209:etiology / Q000473:pathology*
D015415:Biomarkers